Management Paradigm of Central Nervous System Metastases in NSCLC: An Australian Perspective by Chee Khoon Lee, M.B.B.S., PhD, Yu Yang Soon, MSc, Rosalind L. Jeffree, MSc, Rohit Joshi, MD, Eng-Siew Koh, M.B.B.S, Wei-Sen Lam, M.B.B.S., Hien Le, M.B.B.S., Zarnie Lwin, M.B.B.S., Mark B. Pinkham, MA (Hons), Shankar Siva, PhD, Evan Ng, M.B.B.S., Thomas John, PhD

Get full text

Durvalumab, Tremelimumab, and Platinum Chemotherapy in EGFR Mutation–Positive NSCLC: An Open-Label Phase 2 Trial (ILLUMINATE) by Chee Khoon Lee, PhD, Bin-Chi Liao, MD, Shalini Subramaniam, MMed (Clin Epi), Chao-Hua Chiu, MD, Antony J. Mersiades, MMed (Clin Epi), Chao-Chi Ho, MD, PhD, Chris Brown, MBiostats, Chun-Liang Lai, MD, PhD, Brett G.M. Hughes, M.B.B.S. (Hons), Tsung-Ying Yang, MD, PhD, Ken O’Byrne, MD, Yung-Hung Luo, MD, PhD, Sonia Yip, PhD, Ching-Liang Ho, MD, Victoria Bray, PhD, Wu-Chou Su, MD, PhD, Melissa Moore, PhD, Wei-Lien Feng, MS, Ya-Ying Bai, MS, Kate Ford, MHSc, Michelle M. Cummins, PhD, Martin R. Stockler, MSc (Clin Epi), Benjamin J. Solomon, PhD, Thomas John, PhD, James Chih-Hsin Yang, MD, PhD

Get full text